Finnegan is a sponsor of the C5 Life Sciences IP Summit. Finnegan attorney Antje Brambrink will join the panel discussion “Devising Successful Strategies for Procuring and Maintaining Patents in the New Unitary Patent Era,” Bryan Diner will co-present "Maximizing the Chances of Success in a Bet-the-Company Pharmaceutical Litigation," and Caroline Haas will join the panel discussion “Maximizing the Success of Litigation.” Additionally, Ningling Wang will join the panel discussion “Interactive Roundtable on Transnational Tactics for Claiming and Enforcing Formulation, Combination and Second Medical Use Patents.” The conference will take place at the Westin Grand Munich in Munich, Germany. For more information, or to register, please see C5’s website.
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.